Cover Image

Editorial: Cytokine Release Syndrome in COVID-19: Mechanisms and Management

Saved in:

Bibliographic Details
Main Author:	Tao Hu (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19
by: Clarissa S. Santoso, et al.
Published: (2021)

Potential Pathophysiological Mechanisms Underlying Multiple Organ Dysfunction in Cytokine Release Syndrome
by: Peixian Chen, et al.
Published: (2022)

Tocilizumab in a child with acute lymphoblastic leukaemia and COVID-19-related cytokine release syndrome
by: Pablo Velasco Puyó, et al.
Published: (2020)

The Management of Cytokine Storm in COVID-19
by: Cleopas Martin Rumende, et al.
Published: (2020)

Notes from the Field: The Combined Effects of Tocilizumab and Remdesivir in a Patient with Severe COVID-19 and Cytokine Release Syndrome
by: Ali, Sabahat, et al.
Published: (2021)

Current approaches in the grading and management of cytokine release syndrome after chimeric antigen receptor T-cell therapy
by: Riegler LL, et al.
Published: (2019)

Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms
by: Khan MA, et al.
Published: (2021)

Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
by: Zhenguang Wang, et al.
Published: (2018)

Is PBPK useful to inform product label on managing clinically significant drug interactions mediated by cytokine release syndrome?
by: Xinyuan Zhang, et al.
Published: (2024)

A Case of COVID-19-Associated Pediatric Multisystem Inflammatory Syndrome in Shock Managed by Cytokine Filtration
by: Priyanka Lalwani, et al.
Published: (2022)

MECHANISMS OF CYTOKINE STORM DEVELOPMENT IN COVID-19 AND NEW POTENTIAL TARGETS OF PHARMACOTHERAPY
by: V. I. Petrov, et al.
Published: (2021)

Targeting the A3 adenosine receptor to treat cytokine release syndrome in cancer immunotherapy
by: Cohen S, et al.
Published: (2019)

Editorial: COVID-19 and hyper inflammation syndrome: Different presentation and management
by: Dimitri Poddighe, et al.
Published: (2022)

EFIKASI ANTI IL-6 RECEPTOR MONOCLONAL ANTIBODY SEBAGAI TERAPI ADJUVAN PASIEN COVID-19 DENGAN CYTOKINE RELEASE SYNDROME: Sebuah Tinjauan Sistematis
by: Shofiyah Hasya,
Published: (2022)

Immune Checkpoint Inhibitor-Related Cytokine Release Syndrome: Analysis of WHO Global Pharmacovigilance Database
by: Alessandro Ceschi, et al.
Published: (2020)

Spotlight on Tocilizumab in the Treatment of CAR-T-Cell-Induced Cytokine Release Syndrome: Clinical Evidence to Date
by: Si S, et al.
Published: (2020)

Continuous Renal Replacement Therapy With oXiris Filter May Not be an Effective Resolution to Alleviate Cytokine Release Syndrome in Non-AKI Patients With Severe and Critical COVID-19
by: Kai Kang, et al.
Published: (2022)

Cytokine Storm in COVID-19: An Overview, Mechanism, Treatment Strategies, and Stem Cell Therapy Perspective
by: Nuriza Ulul Azmi, et al.
Published: (2020)

Time-dependent cytokines release in specific PRP preparation
by: Chih-Hao Chiu, et al.
Published: (2017)

Kounis syndrome following COVID-19 vaccination: Clinical manifestations, mechanisms and management
by: Chengjie Zhao, et al.
Published: (2024)

Dexmedetomidine Reduced Cytokine Release during Postpartum Bleeding-Induced Multiple Organ Dysfunction Syndrome in Rats
by: Liu Xianbao, et al.
Published: (2013)

Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report
by: Ari Fahrial Syam, et al.
Published: (2021)

Cytokines Torment associated to COVID-19
by: Belén Caridad Santiesteban Rodríguez, et al.
Published: (2022)

Cytokine Profiles in Periodontitis and COVID-19
by: Farhad Hajizadeh, et al.
Published: (2021)

Cytokines and COVID-19: friends or foes?
by: Mohsen Rokni, et al.
Published: (2020)

Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review
by: Quirch, Miguel, et al.
Published: (2020)

Cytokine Release Syndrome Is an Independent Risk Factor Associated With Platelet Transfusion Refractoriness After CAR-T Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia
by: Yadan Liu, et al.
Published: (2021)

Editorial: Eicosanoids and cytokines: Resolution of inflammation
by: Jun-Yan Liu
Published: (2022)

Pembrolizumab-induced cytokine release syndrome with severe encephalopathy in the setting of clear cell vaginal carcinoma: A case report
by: Samantha Metzger, et al.
Published: (2024)

A bibliometric and knowledge-map study of CAR-T cell-related cytokine release syndrome (CRS) from 2012 to 2023
by: Huimin Li, et al.
Published: (2023)

Inflammatory cytokines in scrub typhus and COVID-19
by: S K Farhat, et al.
Published: (2023)

Immunotherapy Summary for Cytokine Storm in COVID-19
by: Yaqun Li, et al.
Published: (2021)

Sequential release of cytokines, lipid mediators and nitric oxide in experimental colitis
by: A. P. M. van Dijk, et al.
Published: (1995)

Editorial: Medication Safety in COVID-19 Management
by: Saibal Das
Published: (2022)

Pentoxifylline Effects on Hospitalized COVID-19 Patients with Cytokine Storm Syndrome: A Randomized Clinical Trial
by: Rania M. Sarhan, et al.
Published: (2023)

Distinct Patterns of Blood Cytokines Beyond a Cytokine Storm Predict Mortality in COVID-19
by: Herr C, et al.
Published: (2021)

Incidence and outcomes of cytokine release syndrome after post haploidentical peripheral blood stem cell transplant with post-transplant cyclophosphamide
by: Shivani Deep, et al.
Published: (2024)

Evaluation of IAP/SMAC mimetics as latency reversal agents in primary cells and cytokine induction in in vivo models predictive of cytokine release
by: B. Howell, et al.
Published: (2019)

Cytokines and Chemokines: Disease Models, Mechanisms, and Therapies
by: Salahuddin Ahmed, et al.
Published: (2014)

The Role of Cytokines in Nephrotic Syndrome
by: Elham Ahmadian, et al.
Published: (2022)